NO20030508L - Tartratsalter av tiazolidindionderivater - Google Patents

Tartratsalter av tiazolidindionderivater

Info

Publication number
NO20030508L
NO20030508L NO20030508A NO20030508A NO20030508L NO 20030508 L NO20030508 L NO 20030508L NO 20030508 A NO20030508 A NO 20030508A NO 20030508 A NO20030508 A NO 20030508A NO 20030508 L NO20030508 L NO 20030508L
Authority
NO
Norway
Prior art keywords
tartrate salts
thiazolidinedione derivatives
thiazolidinedione
derivatives
tartrate
Prior art date
Application number
NO20030508A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030508D0 (no
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael John Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20030508D0 publication Critical patent/NO20030508D0/no
Publication of NO20030508L publication Critical patent/NO20030508L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
NO20030508A 2000-08-04 2003-01-31 Tartratsalter av tiazolidindionderivater NO20030508L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (fr) 2000-08-04 2001-08-03 Sels de tartrate de derive de thiazolidinedione

Publications (2)

Publication Number Publication Date
NO20030508D0 NO20030508D0 (no) 2003-01-31
NO20030508L true NO20030508L (no) 2003-03-20

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030508A NO20030508L (no) 2000-08-04 2003-01-31 Tartratsalter av tiazolidindionderivater

Country Status (23)

Country Link
EP (1) EP1307448A1 (fr)
JP (1) JP2004505971A (fr)
KR (1) KR20030022356A (fr)
CN (1) CN1458930A (fr)
AP (1) AP2003002737A0 (fr)
AU (1) AU2001276508A1 (fr)
BG (1) BG107605A (fr)
BR (1) BR0112984A (fr)
CA (1) CA2417828A1 (fr)
CZ (1) CZ2003314A3 (fr)
EA (1) EA200300231A1 (fr)
EC (1) ECSP034468A (fr)
GB (1) GB0019226D0 (fr)
HU (1) HUP0300770A2 (fr)
IL (1) IL154277A0 (fr)
MA (1) MA25830A1 (fr)
MX (1) MXPA03001086A (fr)
NO (1) NO20030508L (fr)
OA (1) OA12355A (fr)
PL (1) PL360702A1 (fr)
SK (1) SK1452003A3 (fr)
WO (1) WO2002012233A1 (fr)
ZA (1) ZA200300962B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
ECSP034468A (es) 2003-03-31
NO20030508D0 (no) 2003-01-31
IL154277A0 (en) 2003-09-17
BG107605A (bg) 2003-09-30
MXPA03001086A (es) 2003-05-27
CN1458930A (zh) 2003-11-26
EP1307448A1 (fr) 2003-05-07
WO2002012233A1 (fr) 2002-02-14
GB0019226D0 (en) 2000-09-27
EA200300231A1 (ru) 2003-06-26
KR20030022356A (ko) 2003-03-15
JP2004505971A (ja) 2004-02-26
ZA200300962B (en) 2003-10-29
CZ2003314A3 (cs) 2004-02-18
BR0112984A (pt) 2003-06-10
OA12355A (en) 2004-03-19
CA2417828A1 (fr) 2002-02-14
MA25830A1 (fr) 2003-07-01
SK1452003A3 (en) 2004-05-04
PL360702A1 (en) 2004-09-20
HUP0300770A2 (hu) 2003-11-28
AU2001276508A1 (en) 2002-02-18
AP2003002737A0 (en) 2003-03-31

Similar Documents

Publication Publication Date Title
NO20030134L (no) Fremstilling av olefinderivater
DE60223278D1 (de) Nicotin- oder isonicotin benzothiazole derivaten
ATE391505T1 (de) Benzothiazole derivative
NO20030507D0 (no) Tartratsalter av tiazolidindionderivater
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
NO20030508D0 (no) Tartratsalter av tiazolidindionderivater
NO20030530D0 (no) Tartratsalter av tiazolidindionderivater
NO20030531D0 (no) Tartratsalter av tiazolidindionderivater
EE200100381A (et) Morfolinobensamiidi uued soolad
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20025385L (no) Fremgangsmate for fremstilling av sulfonylbenzoylguanidiniumsalter
SI1305310T1 (sl) Tartratne soli derivata tiazolidindiona
HK1057361A (en) Tartrate salts of thiazolidinedione derivative
NO20014451D0 (no) Fremgangsmåte for fremstilling av tiazolidinderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application